Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2025 financial results

11 Feb 2026 17:06 CET

Oslo, Norway, 11 February 2026: Photocure ASA (Photocure, PHO: OSE) will
announce the fourth quarter and preliminary full year 2025 financial results on
Wednesday 18 February 2026 at 08:00 CET and will present a live webcast at 14:00
CET the same day.

The quarterly report and presentation will be published at 07:00 CET and will be
publicly available at www.photocure.com.

The investor presentation will be streamed live and hosted by Dan Schneider, CEO
and Erik Dahl, CFO. The presentation will be held in English and questions can
be submitted throughout the event. The presentation is scheduled to conclude at
14:45 CET.

The streaming event is available through
https://qcnl.tv/p/0MElVGJID9j2vJqcZ9_SbA

For further information, please contact:

Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com

Priyam Shah
Vice President of Investor Relations
Tel: +17176815072
Email: priyam.shah@photocure.com

Media enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com and www.cysview.com.

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site